Pfizer Limited Clears FY26 Results, Recommends Rs 75 Dividend and Sets AGM Date

PFIZER LIMITED ( (IN:PFIZER) ) just unveiled an update.

Pfizer Limited’s board has approved the audited financial results for the year ended March 31, 2026, along with statements of assets, liabilities and cash flows, supported by an unmodified audit opinion from its statutory auditors. The company also confirmed it does not qualify as a Large Corporate under current SEBI norms, reflecting a capital structure without large long-term borrowings or listed debt.

The board recommended a final dividend of Rs. 75 per equity share for FY 2025-26, subject to shareholder approval, with payment expected on or after August 4, 2026, to shareholders on record as of July 17, 2026. Pfizer Limited will hold its 75th Annual General Meeting on July 28, 2026 via video-conferencing, and has appointed M/s. Kishore Bhatia & Associates as cost auditors for FY 2026-27, with their remuneration to be ratified by shareholders.

More about PFIZER LIMITED

Pfizer Limited is an Indian pharmaceutical company focused on developing, manufacturing and marketing prescription medicines and healthcare products. As a key player in the healthcare sector, it serves domestic and international markets with a portfolio spanning multiple therapeutic areas, aligning with regulatory standards and corporate governance norms in India.

Average Trading Volume: 11,709

Technical Sentiment Signal: Buy

Current Market Cap: 220.1B INR

Learn more about PFIZER stock on TipRanks’ Stock Analysis page.